Updates Value of the Market Opportunity in Existing Applications from $2.2 Billion to $2.7 Billion
Announces Market Development and Clinical Initiatives for Expanded Application in…
RMAT Designation reinforces clinical significance of RANGER® registry data and acknowledges the unmet need for improved nerve repair solutions
ALACHUA, Florida—(GLOBE NEWSWIRE)—AxoGen, Inc. (NASDAQ: AXGN),…
Total Transaction Valued in Excess of $500 Million, Representing a 50% Premium
Gurnet Point Capital to Expand Operations While Focusing on the Approval and Commercialization…
NEW YORK, New York – EW Healthcare Partners (“EW”), a leading healthcare growth equity firm with a global investment practice, has announced the addition of…
ALACHUA, Florida—(GLOBE NEWSWIRE)—AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced that Ernst & Young (EY)…
ALACHUA, Florida (GLOBE NEWSWIRE)—AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, announced today that it has priced…
MALVERN, Pennsylvania—Encore Dermatology Inc. announces today the availability of a new topical product, IMPOYZ Cream, indicated for the treatment of moderate to severe plaque psoriasis…
All content © 2025
Legal Disclaimer | Privacy Notice
Powered by 
